Recipharm and Medspray form joint venture Resyca for softmist nozzles

Recipharm will invest EUR 15 million for a 51% stake in a new joint venture, Resyca BV, with Medspray, which will contribute its softmist spray nozzle intellectual property for pharmaceutical applications. The venture will develop and exploit the technology.

“The novel softmist technology represents an opportunity to deliver inhaled therapies in a highly environmentally friendly manner without the need for propellants and less drug being wasted.”kennispark.nl

• 1 source
• kennispark.nlMedspray and Swedish Recipharm join forces - KennisparkNov 19, 2020

Summarized from public sources; check the original articles before acting on it.